We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Colgate to Report Q3 Earnings: What Should Investors Expect?
Read MoreHide Full Article
Key Takeaways
CL's Q3 revenues are projected to rise 3.9% to $5.33 billion, with EPS expected to grow 1.1% to 92 cents.
Emerging-market demand, premium oral-care innovation and Hill's Pet Nutrition may support CL's Q3 results.
Cost-saving initiatives, targeted pricing and AI-driven promotions could help Colgate sustain profitability.
Colgate-Palmolive Company (CL - Free Report) is set to release third-quarter 2026 results on Oct. 30, before the opening bell, with growth expected in both its bottom and top lines. The Zacks Consensus Estimate for third-quarter revenues is pegged at $5.33 billion, indicating a rise of about 3.9% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for the company’s earnings per share (EPS) is pegged at 92 cents, suggesting growth of 1.1% from the prior-year quarter’s reported figure. The consensus estimate for the quarter has remained stable over the past 30 days.
In the last reported quarter, the leading global consumer products company’s earnings beat the Zacks Consensus Estimate by 4.2%. It has delivered an average earnings surprise of 3.2% over the trailing four quarters.
Colgate-Palmolive Company Price, Consensus and EPS Surprise
Our proven model predicts an earnings beat for Colgate this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Colgate currently has an Earnings ESP of +0.01% and a Zacks Rank of 3. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Factors Likely to Influence CL's Q3 Results
Colgate is likely to have benefited from its strong international presence and continued momentum in emerging markets during the third quarter. Strength in India, Brazil, Mexico and China, supported by improving volume trends and sustained brand investments, is expected to have aided sales. The company’s focus on premium offerings, alongside affordable products and suitable pack sizes, might have helped address different consumer needs and expand household penetration. Continued advertising and stronger execution across traditional retail and online channels are also likely to have supported demand.
Science-based innovation and premiumization are expected to have remained important drivers of Colgate’s quarterly performance. The expansion of its whitening portfolio, including Optic White Pro Series with ActivShine Technology and Optic White Purple, might have encouraged purchases of higher-value oral-care products. In Europe, innovation across Colgate, elmex and meridol is likely to have reinforced the company’s premium positioning. Increased distribution and advertising behind recent launches, together with targeted pricing and promotional actions in North America, might have supported sales and a more favorable product mix.
Hill’s Pet Nutrition is also likely to have supported third-quarter performance, backed by its differentiated products and strong veterinary relationships. Therapeutic nutrition, cat food, wet food and products for small dogs offered opportunities to build on existing demand and attract new customers. Continued investment in advertising and online retail is expected to have strengthened the reach of its science-based offerings. International growth opportunities and efforts to increase penetration in specialized nutrition might have further supported sales, while demand for therapeutic products is likely to have benefited the business’s product mix.
Colgate’s focus on productivity and disciplined revenue growth management is expected to have provided additional support to earnings. Its funding-the-growth initiatives aim to reduce costs through manufacturing improvements, supplier consolidation, simpler formulations and more efficient packaging and distribution. These savings, combined with selective pricing and premiumization, might have helped sustain profitability while allowing continued investment in brand building. The expanded use of Promo artificial intelligence (AI) tools is also likely to have improved promotional effectiveness, helping the company direct spending toward activities with stronger returns.
CL’s Price Performance & Valuation
The recent market movements show that Colgate’s shares have gained 11.7% over the past six months compared with the industry's 9.9% growth.
Image Source: Zacks Investment Research
From the valuation standpoint, CL trades at a forward 12-month P/E multiple of 23.32X, exceeding the industry average of 20.16X. Its valuation appears relatively expensive.
Image Source: Zacks Investment Research
Other Stocks With the Favorable Combination
Here are some other companies worth considering, as our model shows that these, too, have the right combination of elements to beat on earnings this reporting cycle.
The Zacks Consensus Estimate for BJ's Wholesale’s upcoming quarterly revenues is pegged at $5.94 billion. The figure indicates an 11.1% increase from the prior-year quarter. The Zacks Consensus Estimate for BJ's Wholesale’s quarterly earnings per share is pegged at $1.22, suggesting a 5.2% rise from the year-ago period figure. BJ delivered a trailing four-quarter earnings surprise of 4.8%, on average.
Newell Brands Inc. (NWL - Free Report) has an Earnings ESP of +2.26% and a Zacks Rank of 3 at present. NWL is likely to register bottom-line growth when it releases third-quarter 2026 results. The consensus estimate for Newell Brands’ quarterly earnings currently stands at 20 cents per share, up 17.7% from the year-ago quarter.
The Zacks Consensus Estimate for its quarterly revenues is pegged at about $1.85 billion, implying a rise of 2.5% from the year-ago quarter. NWL has a trailing four-quarter average earnings surprise of 40%.
Church & Dwight Co. (CHD - Free Report) currently has an Earnings ESP of +0.06% and a Zacks Rank of 3. The company is likely to register bottom-line growth and a decline in its top line when it reports third-quarter 2026 figures.
The Zacks Consensus Estimate for Church & Dwight’s quarterly revenues is pegged at $1.58 billion, indicating a decrease of 0.2% from the figure reported in the prior-year quarter. The consensus estimate for CHD’s quarterly earnings of 90 cents per share implies a rise of 11.1% from the year-ago quarter’s level. CHD has a trailing four-quarter earnings surprise of 3.9%, on average.
View the Zacks #1 Rank List
Image: Bigstock
Colgate to Report Q3 Earnings: What Should Investors Expect?
Key Takeaways
Colgate-Palmolive Company (CL - Free Report) is set to release third-quarter 2026 results on Oct. 30, before the opening bell, with growth expected in both its bottom and top lines. The Zacks Consensus Estimate for third-quarter revenues is pegged at $5.33 billion, indicating a rise of about 3.9% from the prior-year quarter’s reported figure.
The Zacks Consensus Estimate for the company’s earnings per share (EPS) is pegged at 92 cents, suggesting growth of 1.1% from the prior-year quarter’s reported figure. The consensus estimate for the quarter has remained stable over the past 30 days.
In the last reported quarter, the leading global consumer products company’s earnings beat the Zacks Consensus Estimate by 4.2%. It has delivered an average earnings surprise of 3.2% over the trailing four quarters.
Colgate-Palmolive Company Price, Consensus and EPS Surprise
Colgate-Palmolive Company price-consensus-eps-surprise-chart | Colgate-Palmolive Company Quote
What the Zacks Model Unveils for CL Stock
Our proven model predicts an earnings beat for Colgate this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Colgate currently has an Earnings ESP of +0.01% and a Zacks Rank of 3. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Factors Likely to Influence CL's Q3 Results
Colgate is likely to have benefited from its strong international presence and continued momentum in emerging markets during the third quarter. Strength in India, Brazil, Mexico and China, supported by improving volume trends and sustained brand investments, is expected to have aided sales. The company’s focus on premium offerings, alongside affordable products and suitable pack sizes, might have helped address different consumer needs and expand household penetration. Continued advertising and stronger execution across traditional retail and online channels are also likely to have supported demand.
Science-based innovation and premiumization are expected to have remained important drivers of Colgate’s quarterly performance. The expansion of its whitening portfolio, including Optic White Pro Series with ActivShine Technology and Optic White Purple, might have encouraged purchases of higher-value oral-care products. In Europe, innovation across Colgate, elmex and meridol is likely to have reinforced the company’s premium positioning. Increased distribution and advertising behind recent launches, together with targeted pricing and promotional actions in North America, might have supported sales and a more favorable product mix.
Hill’s Pet Nutrition is also likely to have supported third-quarter performance, backed by its differentiated products and strong veterinary relationships. Therapeutic nutrition, cat food, wet food and products for small dogs offered opportunities to build on existing demand and attract new customers. Continued investment in advertising and online retail is expected to have strengthened the reach of its science-based offerings. International growth opportunities and efforts to increase penetration in specialized nutrition might have further supported sales, while demand for therapeutic products is likely to have benefited the business’s product mix.
Colgate’s focus on productivity and disciplined revenue growth management is expected to have provided additional support to earnings. Its funding-the-growth initiatives aim to reduce costs through manufacturing improvements, supplier consolidation, simpler formulations and more efficient packaging and distribution. These savings, combined with selective pricing and premiumization, might have helped sustain profitability while allowing continued investment in brand building. The expanded use of Promo artificial intelligence (AI) tools is also likely to have improved promotional effectiveness, helping the company direct spending toward activities with stronger returns.
CL’s Price Performance & Valuation
The recent market movements show that Colgate’s shares have gained 11.7% over the past six months compared with the industry's 9.9% growth.
Image Source: Zacks Investment Research
From the valuation standpoint, CL trades at a forward 12-month P/E multiple of 23.32X, exceeding the industry average of 20.16X. Its valuation appears relatively expensive.
Image Source: Zacks Investment Research
Other Stocks With the Favorable Combination
Here are some other companies worth considering, as our model shows that these, too, have the right combination of elements to beat on earnings this reporting cycle.
BJ's Wholesale Club (BJ - Free Report) currently has an Earnings ESP of +2.54% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for BJ's Wholesale’s upcoming quarterly revenues is pegged at $5.94 billion. The figure indicates an 11.1% increase from the prior-year quarter. The Zacks Consensus Estimate for BJ's Wholesale’s quarterly earnings per share is pegged at $1.22, suggesting a 5.2% rise from the year-ago period figure. BJ delivered a trailing four-quarter earnings surprise of 4.8%, on average.
Newell Brands Inc. (NWL - Free Report) has an Earnings ESP of +2.26% and a Zacks Rank of 3 at present. NWL is likely to register bottom-line growth when it releases third-quarter 2026 results. The consensus estimate for Newell Brands’ quarterly earnings currently stands at 20 cents per share, up 17.7% from the year-ago quarter.
The Zacks Consensus Estimate for its quarterly revenues is pegged at about $1.85 billion, implying a rise of 2.5% from the year-ago quarter. NWL has a trailing four-quarter average earnings surprise of 40%.
Church & Dwight Co. (CHD - Free Report) currently has an Earnings ESP of +0.06% and a Zacks Rank of 3. The company is likely to register bottom-line growth and a decline in its top line when it reports third-quarter 2026 figures.
The Zacks Consensus Estimate for Church & Dwight’s quarterly revenues is pegged at $1.58 billion, indicating a decrease of 0.2% from the figure reported in the prior-year quarter. The consensus estimate for CHD’s quarterly earnings of 90 cents per share implies a rise of 11.1% from the year-ago quarter’s level. CHD has a trailing four-quarter earnings surprise of 3.9%, on average.